Clinical Trial Update: A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 randomized study compares AAT-023 (Zuragen) solution with heparin for preventing catheter-related bloodstream infections in tunneled chronic central v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• AAT-023 (Zuragen) solution (AAT-023)
• Heparin (unfractionated heparin)

Snippet

Sponsor: Ash Access Technology | Conditions: End Stage Renal Disease | Phase 3 | Status: UNKNOWN